semaglutide and sickness Comparative safety side effects of and tirzepatide: Implications for clinical decision-making in obesity management Ozempic: Semaglutide is a GLP-1

Reduced gastrointestinal motility throughout the digestive tract prolongs the period during which nutrient sensors in the gut wall send satiety signals

Whilst GLP-1 therapies improve insulin sensitivity, promote weight loss, and reduce visceral fatfactors that can influence the hypothalamic-pituitary-adrenal axisthey are not licensed or recommended for treating hypercortisolism

You cannot do this directly

Meal prep on weekends to ensure you always have nutritious options ready

Caldwell Cardiovascular Research.2017

If you're carrying excess weight, it's worth considering embarking on a journey towards a healthier you